Corvus Pharmaceuticals
CRVS
CRVS
123 hedge funds and large institutions have $359M invested in Corvus Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
6.5% more ownership
Funds ownership: 55.93% → 62.43% (+6.5%)
8% less call options, than puts
Call options by funds: $4.76M | Put options by funds: $5.15M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
123
Holding in Top 10
1
Calls
$4.76M
Puts
$5.15M
Top Buyers
| 1 | +$23.3M | |
| 2 | +$21.6M | |
| 3 | +$14.1M | |
| 4 |
DA
DCF Advisers
Greenwich,
Connecticut
|
+$5.75M |
| 5 |
Millennium Management
New York
|
+$5.43M |
Top Sellers
| 1 | -$28.2M | |
| 2 | -$17.6M | |
| 3 | -$5.88M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$3.05M |
| 5 |
FCMV
Foresite Capital Management VI
Larkspur,
California
|
-$2.76M |
